Morse Asset Management’s Pfizer PFE Stock Holding History

Morse Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$433	Hold	18	–	–	﹤0.01%	400
2026 Q1	$505	Sell	18 -530	-97%	-$14.1K	﹤0.01%	383
2025 Q4	$13.6K	Hold	548	–	–	﹤0.01%	272
2025 Q3	$14K	Buy	548 +40	+8%	+$987	﹤0.01%	251
2025 Q2	$12.3K	Buy	508 +290	+133%	+$6.76K	﹤0.01%	252
2025 Q1	$5.52K	Buy	218 +200	+1,111%	+$5.23K	﹤0.01%	268
2024 Q4	$478	Sell	18 -91,503	-100%	-$2.48M	﹤0.01%	317
2024 Q3	$2.65M	Buy	+91,521	New	+$2.67M	0.57%	49
2021 Q4	–	Sell	-6,000	Closed	-$258K	–	181
2021 Q3	$258K	Buy	+6,000	New	+$266K	0.06%	148
2020 Q4	–	Sell	-9,718	Closed	-$338K	–	153
2020 Q3	$338K	Buy	+9,718	New	+$341K	0.11%	105
2017 Q2	–	Sell	-9,157	Closed	-$297K	–	133
2017 Q1	$297K	Buy	+9,157	New	+$289K	0.1%	114

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morse Asset Management's PFE Position: Q2 2026 in Review

Morse Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 18 shares worth $433. The position accounts for ﹤0.01% of the portfolio, ranked #400.

Morse Asset Management first reported a position in PFE in Q1 2017 and has held it in 11 quarters since. The position peaked at $2.65M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Morse Asset Management held 18 shares of Pfizer worth $433 as of Q2 2026.
Morse Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Morse Asset Management's portfolio in Q2 2026, its #400 holding.
Morse Asset Management first reported a position in Pfizer in Q1 2017 and has held it in 11 quarters since.
Morse Asset Management's Pfizer position peaked at $2.65M in Q3 2024.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.